Phone:

+91-79-6632 4946

Email:

chirantanc@iima.ac.in

Website:

https://sites.google.com/view/chirantanonline/

Prof. Chirantan Chatterjee

Business Policy, Economics | ICICI Bank Chair in Strategic Management

Educational Qualifications

  • Ph.D. Public Policy & Management, Heinz College, Carnegie Mellon University, June 2011.
    • Dissertation: Intellectual Property, Incentives for Innovation and Welfare: Evidence from the Global Pharmaceutical Industry | Dissertation funding support: National Science Foundation SCISIP Grant #0830233.
  • M.Phil. Public Policy & Management, Heinz College, Carnegie Mellon University, 2010.
  • MBA (PGDCM with Major in Economics), Indian Institute of Management, Calcutta, 2001-2003.
  • B. Tech. (Major: Civil Engineering), Indian Institute of Technology Roorkee, 1997-2001.

Academic Affiliation

  • Current Affiliation: Associate Professor in Business Policy & Economics | ICICI Bank Chair in Strategic Management | Indian Institute of Management, Ahmedabad
  • Past Affiliations:
    • 2017 – 2018 | Economics & Public Policy, Indian School of Business.
      • Assistant Professor; Bharti & Max Institute Research Fellow in Public Policy and Healthcare.
    • 2011 – 2017 | Corporate Strategy & Policy, Indian Institute of Management, Bangalore.
      • Assistant Professor and Young Faculty Research Chair (2012-2015).
    • Fall 2014 | Indian School of Business (Visiting Faculty, Indian Healthcare Systems & Services).
    • 2014–16 | India Japan IJEP Collaborative Program, University of Tokyo
      • Faculty Member, Technology Management & Innovation Economics

Professional Affiliation

 

 

Teaching

  • MBA & Executive MBA
    1. Indian Healthcare Systems & Services (Indian School of Business)
    2. Redefining Hospital Management (Johnson & Johnson Program for Hospital CXOs, 3 Cycles).
    3. Competition & Strategy & Rise of the Asian Economies (IIM-Bangalore).
    4. Doing Business in India (NYU-Stern School Visiting students at IIM Bangalore).
    5. Managerial Economics, Economics & Management of Bio-pharmaceutical Industry (ISB).
    6. Corporate Strategy, Redefining Hospital Management, Women Leaders in Corporate India (Wockhardt, Micro-Labs, JDA Software, Johnson & Johnson, Novartis).
    7. Management of Technology Innovation listed here at The Economist.
  • Undergraduate & Masters
    1. Economic Principles of Policy Analysis, Managerial Economics, Management of Industrial R&D, Global Economy & Technology and Economic Growth (Carnegie Mellon University).
  • Doctoral Courses
    1. Economics of Innovation, Technological Change & Growth (IIM-Bangalore).
    2. Laboratory of Empirical Industrial Organization (IIM-Bangalore).
  • edX-IIMBx MOOC Courses
    1. IIMBx course: ST260x Healthcare in India: Strategic Perspectives

Research Interests

 

Publications/Articles/Cases

[1] Adbi, A, Chatterjee, C., Drev, M., & Mishra, A. (2018). When the Big One Came: A Natural Experiment on Demand Shocks and Market Structure in India's Influenza Vaccine Markets. Accepted and forthcoming, Production and Operations Management.

[2] Adbi, A., Bhaskarabhatla, A.S., Chatterjee, C. (2018). Stakeholder Orientation and Market Impact: Evidence from India. Journal of Business Ethics.

[3] Chatterjee, C., Joshi, R., Sood, N., & Boregowda, P. (2018). Government health insurance and spatial peer effects: New evidence from India. Social Science & Medicine, 196, 131-141.

[4] Chakraborty, P. & Chatterjee, C. (2017). Does Environmental Regulation Indirectly Induce Upstream Innovation? New Evidence from India. Research Policy, 46(5), 939-955.

[5] Bhaskarabhatla, A., & Chatterjee, C. (2017). The role of physicians in prescribing irrational fixed-dose combination medicines in India. Social Science & Medicine, 174, 179-187.

[6] Bhaskarabhatla, A. Chatterjee, C., Anurag, P., Pennings, E. (2017). Mitigating regulatory impact: the case of partial price controls on metformin in India. Health Policy and Planning, 32 (2), 194-204.

[7] Bhaskarabhatla, A., & Chatterjee, C. (2017). Whither competition law in Indian pharmaceutical markets? Evidence from arbitration data of CCI and COMPAT. Journal of Antitrust Enforcement.

[8] Adbi, A., Faizi, N., & Chatterjee, C. (2017). Analyzing the Lazy Mother Argument Inspired by the Maggi Controversy. Economic & Political Weekly, 52(28), 49.

[9] Branstetter, L., Chatterjee, C., & Higgins, M. J. (2016). Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry. The RAND Journal of Economics, 47(4), 857-890. NBER Working Paper 17188.

[10] Bhaskarabhatla, A., Chatterjee, C. Bas Karreman (2016). Hit where it hurts: Cartel policing using targeted sales embargoes in markets for medicines. The Journal of Law & Economics, 59(4), 805-846.

[11] Pingali, V., Chaudhuri, M.K., Malik, P., Tamara, R., Kakkar, A. Chatterjee, C., Mondal, S., Sokol, D. Daniel. (2016). Competition Law in India: Perspectives. Vikalpa 41: 168-193.

[12] Chatterjee, C., Kubo, K., & Pingali, V. (2015). The consumer welfare implications of governmental policies and firm strategy in markets for medicines. Journal of Health Economics, 44, 255-273.

[13] Chatterjee, C., Pingali, V. (2015). Balancing Affordability and Availability in a Drug Patent Regime. Economic & Political Weekly, 50(41), 20-23.

[14] Chatterjee, C., Kubo, K., Pingali, V. (2013). Crocin or paracetamol – What should the doctor prescribe. Economic & Political Weekly Vol - XLVIII No. 41.

 

Case Studies & Book Chapters:

[1] Roposo.com: Share Your Style: Entrepreneurial Pivoting & Strategic Thinking in Indian Fashion Social Networking - Harvard Business Publishing Case Study (with Reechal Vardhan and available here).

[2] Chatterjee, C. & Mahendiran, S. (2017). The emerging market for biological drugs in India. India & Innovation, Oxford University Press (India) & University of Pennsylvania.

[3] Chatterjee, C. (2009). The historical evolution of post-TRIPs modern Indian pharmaceuticals. Prescribing cultures and pharmaceutical policy. Asia-Pacific 2009, K. Eggleston ed. Walter H. Shorenstein Asia-Pacific Research Center, The Brookings Press.

 

Consulting

  • The World Bank, Private & Financial Sector Development Unit. Short Term Consultant, Project on East European Innovation & International Co-Invention (2008).
  • The World Bank, South Asia Health Nutrition and Population Unit, Short Term Consultant, Project on Impact Evaluation of Rural Tertiary Health Insurance, Karnataka (2011-2012).
  • Indian Pharmaceutical Alliance, Coauthored Research Study, (2014).

 

Awards & Honors

  • W. Glenn Campbell and Rita Ricardo Campbell National Fellow at the Hoover Institution, Stanford University (September 1, 2018 - August 31, 2019) on leave from IIM Ahmedabad.
  • India Japan IJEP Collaborative Program, University of Tokyo (Faculty Member, Technology Management & Innovation Economics)
  • Invited Chair, Round Table on IP and Access to Medicines at 2017 Annual Conference of European Policy for Intellectual Property, Bordeaux France.
  • Invited Speaker, Bates White Lifesciences Economics Conference 2016.
  • Invited Speaker, Hoover IP2 Conference 2016, Stanford University.
  • Invited Faculty Panel Moderator, The 2017 Paul Janssen TB Symposium, CSIR-IMTECH.
  • Advisory inputs, NITI Aayog Tarun Khanna Committee on National Innovation System India, 2015.
  • Faculty Invitee, 2015 Inaugural Conference of the World Bank Group-OECD Global Expert Network on Competition Policy, Shared Prosperity and Inclusive Growth.
  • Faculty Invitee, 2015 Annual Searle Center Research Roundtable on Patents and Technology Standards: The Data Sets, Northwestern University.
  • 2015 Pfizer Research Grant as co-PI of USD 27000.
  • Research cited at NSF Science of Science Policy Website (see: http://www.scienceofsciencepolicy.net/node/9484) & NBER January 2015 digest (see: http://www.nber.org/digest/jan15/w20532.html)
  • Qualcomm University Initiatives Grant of USD 103000 for 1st India Conference on Innovation, Intellectual Property & Competition (Conference Organizing Committee Chair) along with support from Tata Trusts, WIPRO, ZEE Network among other Indian sponsors of this conference.
  • Best Paper, Atlanta Competitive Advantage Conference 2013 for ‘First Mover Advantages Before and After TRIPS: Evidence from Indian Pharmaceutical Industry'.
  • Panel Invitee, "Globalizing Innovation: The Current Discourse", Academy of Management 2014.
  • Panel Invitee, University of Pennsylvania, Special Conference on ‘India & Innovation, November 2013.
  • Faculty Invitee, 1st Google-India Faculty Summit 2013.
  • Faculty Invitee, Conference on Pharmaceuticals, Competition Commission of India 2013.
  • Finalist, Barry M. Richman Best Doctoral Dissertation Award. Academy of Management, International Management Division. 2012.
  • Young Faculty Research Chair & Visiting Research Scholars Program, Indian Institute of Management, Bangalore.
  • Best Paper Award for ‘Emerging Economies' track, Academy of International Business 2010.
  • Temple/AIB Best Paper Award Nominee, Academy of International Business 2010.
  • Sloan Foundation Travel Grant 2005 & 2008-2009 for doctoral research.

 

Social Media

 
 
Staging Enabled